[
1. Rizalar FS, Roosen DA, Haucke V. A Presynaptic Perspective on Transport and Assembly Mechanisms for Synapse Formation. Neuron. 2021;109(1):27-41. doi:10.1016/j.neuron.2020.09.03833098763
]Open DOISearch in Google Scholar
[
2. Perez DM. α1-Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition. Frontiers in Pharmacology. 2020;11. https://www.frontiersin.org/articles/10.3389/fphar.2020.58109810.3389/fphar.2020.581098755305133117176
]Search in Google Scholar
[
3. Szabadi E. Introduction to Neuropsychopharmacology. Br J Clin Pharmacol. 2009;68(6):965. doi:10.1111/j.1365-2125.2009.03529.x
]Open DOISearch in Google Scholar
[
4. Nguyen PV, Connor SA. Noradrenergic Regulation of Hippocampus-Dependent Memory. Cent Nerv Syst Agents Med Chem. 2019;19(3):187-196. doi:10.2174/187152491966619071916363231749419
]Open DOISearch in Google Scholar
[
5. Ordway GA, Schwartz MA, Frazer A. Brain Norepinephrine: Neurobiology and Therapeutics. Cambridge University Press; 2007.10.1017/CBO9780511544156
]Search in Google Scholar
[
6. Langer SZ. α2-Adrenoceptors in the treatment of major neuropsychiatric disorders. Trends Pharmacol Sci. 2015;36(4):196-202. doi:10.1016/j.tips.2015.02.00625771972
]Open DOISearch in Google Scholar
[
7. Kobayashi M, Sasabe T, Shiohama Y, Koshikawa N. Activation of alpha1-adrenoceptors increases firing frequency through protein kinase C in pyramidal neurons of rat visual cortex. Neurosci Lett. 2008;430(2):175-180. doi:10.1016/j.neulet.2007.10.04718061348
]Open DOISearch in Google Scholar
[
8. Velásquez-Martinez MC, Vázquez-Torres R, Jiménez-Rivera CA. Activation of alpha1-adrenoceptors enhances glutamate release onto ventral tegmental area dopamine cells. Neuroscience. 2012;216:18-30. doi:10.1016/j.neuroscience.2012.03.056380908022542873
]Open DOISearch in Google Scholar
[
9. Salgado H, Garcia-Oscos F, Patel A, et al. Layer-specific noradrenergic modulation of inhibition in cortical layer II/III. Cereb Cortex. 2011;21(1):212-221. doi:10.1093/cercor/bhq081300057120466749
]Open DOISearch in Google Scholar
[
10. Bellinger DL, Lorton D. Autonomic regulation of cellular immune function. Auton Neurosci. 2014;182:15-41. doi:10.1016/j.autneu.2014.01.00624685093
]Open DOISearch in Google Scholar
[
11. RxList - The Internet Drug Index for prescription drug information, interactions, and side effects. RxList. Accessed October 7, 2022. https://www.rxlist.com/
]Search in Google Scholar
[
12. Alpha 1 Adrenergic Receptor Antagonists. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases; 2012. http://www.ncbi.nlm.nih.gov/books/NBK548719/
]Search in Google Scholar
[
13. Datta D, Yang ST, Galvin VC, et al. Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex. J Neurosci. 2019;39(14):2722-2734. doi:10.1523/JNEUROSCI.2472-18.2019644599330755491
]Open DOISearch in Google Scholar
[
14. Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999;60 Suppl 4:4-11; discussion 12-13.10.4088/JCP.v60n1204
]Search in Google Scholar
[
15. Kovich H, DeJong A. Common Questions About the Pharmacologic Management of Depression in Adults. Am Fam Physician. 2015;92(2):94-100.
]Search in Google Scholar
[
16. Born GVR, Banks P. Hugh Blaschko, 4 January 1900 - 18 April 1993. Biographical Memoirs of Fellows of the Royal Society. 1996;42:40-60. doi:10.1098/rsbm.1996.0004
]Open DOISearch in Google Scholar
[
17. Rubin RP. Hermann (Hugh) Blaschko (1900-1993): His fundamental contributions to biochemical pharmacology and clinical medicine. J Med Biogr. 2019;27(3):179-183. doi:10.1177/096777201770309130848165
]Open DOISearch in Google Scholar
[
18. Taylor BN, Cassagnol M. Alpha Adrenergic Receptors. StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK539830/
]Search in Google Scholar
[
19. Haj-Dahmane S, Shen RY. Chronic stress impairs α1-adrenoceptor-induced endocannabinoid-dependent synaptic plasticity in the dorsal raphe nucleus. J Neurosci. 2014;34(44):14560-14570. doi:10.1523/JNEUROSCI.1310-14.2014421206125355210
]Open DOISearch in Google Scholar
[
20. Paudel S, Wang S, Kim E, et al. Design, Synthesis, and Functional Evaluation of 1, 5-Disubstituted Tetrazoles as Monoamine Neurotransmitter Reuptake Inhibitors. Biomol Ther (Seoul). 2022;30(2):191-202. doi:10.4062/biomolther.2021.119890245934789584
]Open DOISearch in Google Scholar
[
21. Hamon M, Blier P. Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:54-63. doi:10.1016/j.pnpbp.2013.04.00923602950
]Open DOISearch in Google Scholar
[
22. Velásquez-Martínez MC, Vázquez-Torres R, Rojas LV, Sanabria P, Jiménez-Rivera CA. Alpha-1 adrenoreceptors modulate GABA release onto ventral tegmental area dopamine neurons. Neuropharmacology. 2015;88:110-121. doi:10.1016/j.neuropharm.2014.09.002425251825261018
]Open DOISearch in Google Scholar
[
23. Oberbeck R, Schmitz D, Wilsenack K, et al. Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation. 2004;11(4):214-223. doi:10.1159/00007843915249727
]Open DOISearch in Google Scholar
[
24. Pongratz G, Straub RH. The sympathetic nervous response in inflammation. Arthritis Res Ther. 2014;16(6):504. doi:10.1186/s13075-014-0504-2439683325789375
]Open DOISearch in Google Scholar
[
25. Starke K, Göthert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989;69(3):864-989. doi:10.1152/physrev.1989.69.3.8642568648
]Open DOISearch in Google Scholar
[
26. Uys MM, Shahid M, Harvey BH. Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia—New Developments and Future Perspective. Frontiers in Psychiatry. 2017;8. https://www.frontiersin.org/articles/10.3389/fpsyt.2017.0014410.3389/fpsyt.2017.00144555805428855875
]Search in Google Scholar
[
27. Brosda J, Jantschak F, Pertz HH. α2-Adrenoceptors are targets for antipsychotic drugs. Psychopharmacology (Berl). 2014;231(5):801-812. doi:10.1007/s00213-014-3459-824488407
]Open DOISearch in Google Scholar
[
28. Cottingham C, Wang Q. α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy. Neurosci Biobehav Rev. 2012;36(10):2214-2225. doi:10.1016/j.neubiorev.2012.07.011350831022910678
]Open DOISearch in Google Scholar
[
29. Srivastava AB, Mariani JJ, Levin FR. New directions in the treatment of opioid withdrawal. Lancet. 2020;395(10241):1938-1948. doi:10.1016/S0140-6736(20)30852-7738566232563380
]Open DOISearch in Google Scholar
[
30. Holzer P, Holzer-Petsche U. Pharmacology of inflammatory pain: local alteration in receptors and mediators. Dig Dis. 2009;27(0 1):24-30. doi:10.1159/000268118437082920203494
]Open DOISearch in Google Scholar
[
31. Ju JY, Kim KM, Lee S. Effect of preoperative administration of systemic alpha-2 agonists on postoperative pain: a systematic review and meta-analysis. Anesth Pain Med (Seoul). 2020;15(2):157-166. doi:10.17085/apm.2020.15.2.157771382633329808
]Open DOISearch in Google Scholar
[
32. Spieth PP, Geier C, Reske AW. Alpha-2 agonists: back to the future of human anesthesia? Minerva Anestesiol. 2015;81(10):1058-1060.
]Search in Google Scholar
[
33. Zhang X, Bai X. New therapeutic uses for an alpha2 adrenergic receptor agonist--dexmedetomidine in pain management. Neurosci Lett. 2014;561:7-12. doi:10.1016/j.neulet.2013.12.03924373989
]Open DOISearch in Google Scholar
[
34. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52(4):595-638.
]Search in Google Scholar
[
35. Kerage D, Sloan EK, Mattarollo SR, McCombe PA. Interaction of neurotransmitters and neurochemicals with lymphocytes. Journal of Neuroimmunology. 2019;332:99-111. doi:10.1016/j.jneuroim.2019.04.00630999218
]Open DOISearch in Google Scholar
[
36. Bergquist J, Tarkowski A, Ekman R, Ewing A. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proceedings of the National Academy of Sciences. 1994;91(26):12912-12916. doi:10.1073/pnas.91.26.12912
]Open DOISearch in Google Scholar
[
37. Cosentino M, Fietta AM, Ferrari M, et al. Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood. 2007;109(2):632-642. doi:10.1182/blood-2006-01-02842316985181
]Open DOISearch in Google Scholar
[
38. Yamaguchi I, Kopin IJ. Plasma catecholamine and blood pressure responses to sympathetic stimulation in pithed rats. American Journal of Physiology-Heart and Circulatory Physiology. 1979;237(3):H305-H310. doi:10.1152/ajpheart.1979.237.3.H305474768
]Open DOISearch in Google Scholar
[
39. Jang HS, Kim J, Padanilam BJ. Renal sympathetic nerve activation via α2-adrenergic receptors in chronic kidney disease progression. Kidney Res Clin Pract. 2019;38(1):6-14. doi:10.23876/j.krcp.18.0143648196930831675
]Open DOISearch in Google Scholar
[
40. Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev. 2003 Jul;16(3):379-414. doi: 10.1128/CMR.16.3.379-414.2003. PMID: 12857774; PMCID: PMC164216.16421612857774
]Open DOISearch in Google Scholar
[
41. Ferreira J. The Theory is Out There: The Use of ALPHA-2 Agonists in Treatment of Septic Shock. Shock. 2018;49(4):358-363. doi:10.1097/SHK.000000000000097928858141
]Open DOISearch in Google Scholar
[
42. Anwar MS, Iskandar MZ, Parry HM, Doney AS, Palmer CN, Lang CC. The future of pharmacogenetics in the treatment of heart failure. Pharmacogenomics. 2015;16(16):1817-1827. doi:10.2217/pgs.15.12026555119
]Open DOISearch in Google Scholar